Previous Article | Next Article 
Journal of Clinical Microbiology, May 1998, p. 1232-1235, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Growth and Survival of Helicobacter
pylori in Defined Medium and Susceptibility to Brij
78
N.
Albertson,
I.
Wenngren, and
J.-E.
Sjöström*
Department of Cell Biology and Biochemistry,
Preclinical Research and Development, Astra Hässle AB,
Mölndal, Sweden
Received 30 September 1997/Returned for modification 19 December
1997/Accepted 11 February 1998
 |
ABSTRACT |
The gastrointestinal pathogen Helicobacter pylori
requires supplementation with either fetal calf serum (FCS),
bovine serum albumin (BSA), or (2,6-dimethyl)-
-cyclodextrin
(CD) for growth in a complex or defined medium. Because the
availability of medium in which all components were chemically defined
would facilitate metabolic studies of H. pylori, growth of
the type strain, ATCC 43504, was compared in a defined medium with
different growth additives. The dependency of H. pylori
growth on FCS or BSA in a defined medium could partially be replaced by
dependency on CD and cholesterol when the last two components were both
added to the defined medium. Growth and cell yield were not affected by
the addition of glucose, but the culture viability (numbers of CFU per
milliliter was extended. Because therapeutic antifoams are used to
relieve gastrointestinal symptoms we studied whether the unique
susceptibility of H. pylori to the emulsifier
polyoxyethylene-20-stearylether (Brij 78) was growth dependent or
medium specific. The bactericidal activity exerted in buffer at pH 5 was independent of the preculture medium, and a 5-h exposure of the
bacteria to 1.28 to 2.56 µg of Brij 78 per ml reduced the numbers of
viable bacteria by >5 log10. The MICs (0.16 to 0.32 µg/ml) were lower than the corresponding minimal bactericidal
concentrations in different growth media and were affected by FCS or
BSA. In conclusion, CD plus cholesterol promotes the growth of H. pylori in a serum-free defined medium in which glucose enhances
cell viability. The antibacterial activity exerted by Brij 78 is
neither growth dependent nor medium specific.
 |
INTRODUCTION |
Cultivation of the gastrointestinal
pathogen Helicobacter pylori (2, 15, 17, 24) in
complex medium for routine laboratory procedures and for large-scale
fermentations (5) requires supplementation of the growth
medium with blood factors (27). However,
(2,6-dimethyl)-
-cyclodextrin (CD) also supports the growth of
H. pylori (23). This has important implications for the production of antigens and enzymes, since H. pylori appears to maintain its biochemical
characteristics and antigenic properties in a serum-free medium.
Bovine serum albumin (BSA) reduces the toxic effects of fatty acids,
which inhibit the growth of H. pylori (11, 14, 21, 25), and CD probably acts in the same way by binding the toxic metabolites produced by the bacteria. However, blood and serum may
contain other growth-stimulatory factors required by helicobacters.
Defined media for H. pylori have been described by
Nedenskov (20) and Reynolds and Penn (26). These
media support the growth of different strains in the presence of amino
acids and in the presence of amino acids and BSA, respectively.
However, very little is known about the nutritional requirements of
this pathogen, and its capability to ferment saccharides has been
discussed previously. Recent evidence indicates that H. pylori can catabolize glucose (18, 19). The complete
genome sequence of H. pylori, which has been published
previously (28), further increases our ability to understand
the biology and evolution of this bacterium, and studies of its growth
in a defined medium may replace or complement nuclear magnetic
resonance studies (3).
The purpose of the study described here was to evaluate the growth of
H. pylori in a medium in which all components were
chemically defined and to determine the effect of an oxidizable
substrate on growth yield and cell viability. Furthermore, we
investigated whether the antibacterial activity exerted by
polyoxyethylene-20-stearylether (Brij 78) (13) was
medium dependent because antifoams with similar properties are used as
alimentary therapeutic agents.
(Part of this study was presented at the IXth International Workshop on
Gastroduodenal Pathology and Helicobacter pylori, Copenhagen, Denmark, 16 to 19 October 1996.)
 |
MATERIALS AND METHODS |
Bacteria and growth conditions.
The H. pylori type strain, ATCC 43504, was used in this study and was
stored at
70°C in brucella broth (BB; pH 7.0; Difco, Detroit,
Mich.) with 10% fetal calf serum (FCS; Gibco BRL, Life Technologies,
Paisley, Scotland) supplemented with 20% glycerol (Prolabo, Paris,
France). The solid medium was Columbia blood agar, which consisted of
42.5 g of Columbia Agar Base II (Becton Dickinson, Cockesville,
Md.) per liter, 15 g of Bacto Agar (Difco) per liter, 7% horse
blood, and 1.0% IsoVitaleX (pH 7.3 ± 0.2); Beckton-Dickinson).
The defined medium was prepared as described by Reynolds and Penn
(26), with all the inorganic chemicals, carbon sources, and
supplemented amino acids being from Sigma (St. Louis, Mo.), since
strain ATCC 43504 is auxotrophic for Met, Ala, Arg, His, Ile, Leu, Phe,
and Val. The medium supplements studied were 10% FCS, 0.1% CD
(Sigma), 0.5% BSA (fraction V powder; minimum, 98%; Sigma), or 2.0 µg of cholesterol (99+%; catalogue no. C 3045; Sigma) per ml. The
organisms growing on agar plates and in liquid cultures in flasks on a
platform shaker (Unimax 2010; Heidolph, Kelheim, Germany) at 150 rpm at
37°C were incubated in an automatic CO2-O2
incubator (Forma Scientific, Inc. Marietta, Ohio) under microaerophilic
conditions (85% N2, 10% CO2, 5%
O2). The growth in liquid medium was monitored at 560 nm,
and viable counts (numbers of CFU per milliliter) were determined on
Columbia blood agar plates after dilution in phosphate-buffered saline (pH 7.2) and 3 days of incubation at 37°C. Unless stated otherwise, the results presented here are representative of the results of three
experiments.
Determination of MICs and MBCs.
Bacteria grown for 2 days on
Columbia blood agar were washed twice in phosphate-buffered saline by
centrifugation at 17,000 × g for 10 min at room
temperature and were resuspended in BB supplemented with 10% FCS or
defined medium with different supplements. MICs and minimal
bactericidal concentrations (MBCs) were then determined by twofold
serial dilution of Brij 78 in the respective medium in the presence of
approximately 106 CFU/ml. After 72 h of incubation,
the MIC was determined by reading the optical density at 560 nm, and 10 µl from each well was applied with a replicator to large Columbia
blood agar plates (120 by 120 by 17 mm). The plates were incubated for
72 h before determination of the MBCs. Brij 78 was tested over a
concentration range of 0.01 to 82 µg/ml. The MIC and the MBC were
defined as the lowest concentrations of the compound giving complete
inhibition of growth and <10 colonies per spot, respectively
(28).
Determination of bactericidal activity in buffer at pH 5.
Bacteria grown on Columbia blood agar or on defined agar medium with
different additives were washed as described above. The bacteria were
then resuspended in sterile 100 mM citrate-phosphate buffer (pH 5).
Twofold serial dilutions of the compound in buffer with approximately
106 CFU/ml were incubated in microtiter plates for 5 h, and the lowest concentration of the compound reducing the viable
counts by >5 log10 was determined by dilution and replica
plating onto large Columbia blood agar plates, which were read after
72 h of incubation.
 |
RESULTS |
Growth of H. pylori in complex and defined media
supplemented with FCS or CD.
In order to investigate the
requirements for growth factors and the compounds involved in the
binding of toxic metabolites, BB and defined medium were supplemented
with FCS or CD. The results in Fig. 1A
indicate that there was no growth of H. pylori in BB alone. The enhancement of H. pylori growth was similar
in BB in the presence of 10% FCS or BB in the presence of 0.1% CD,
resulting in about 4 × 108 CFU/ml and the same loss
of viability on further incubation. In defined medium (Fig. 1B), CD was
not able to promote growth. The growth yield in the presence of 10%
FCS was good and almost comparable to that obtained in the complex
medium with the same additive.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Growth of H. pylori ATCC 43504 in BB (A)
and defined medium (B) supplemented with different additives: no
additive ( ), 10% FCS ( ), and 0.1% CD ( ). Growth was
determined by estimation of viable counts (numbers of CFU per
milliliter.
|
|
Growth patterns of H. pylori in a defined medium
supplemented with different growth additives.
In order to find a
medium for helicobacters in which all the constituents are chemically
defined, the growth of H. pylori was studied in a
defined medium with 0.2% glucose and different growth additives.
Figure 2 shows the growth patterns in a
defined medium supplemented with BSA (0.5%), CD (0.1%), or
cholesterol (2.0 µg/ml). In this medium, neither CD nor cholesterol
alone promoted growth, but the addition of both compounds to the
defined medium resulted in growth that was about half of that obtained in the defined medium with BSA. The growth was initiated after a short
lag period but ceased after about 24 h of incubation. The optical
density was not changed when incubation was prolonged to 72 h.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Growth patterns of H. pylori ATCC 43504 in a defined medium with 0.2% glucose supplemented with different
additives. , defined medium; , defined medium plus 2.0 µg of
cholesterol per ml; , defined medium plus 0.1% CD; , defined
medium plus 2.0 µg of cholesterol per ml plus 0.1% CD; , defined
medium plus 0.5% BSA. Growth was determined by reading the optical
density at 560 nm (OD560).
|
|
Effects of different carbon sources on growth and viability of
H. pylori in a defined medium.
We studied the
effects of an additional carbon source on the growth and yield of
H. pylori cells by adding 0.2 or 1.0% glucose to
defined medium supplemented with 0.5% BSA. No differences in growth or
cell yield (numbers of CFU per milliliter) were observed (Fig.
3). Furthermore, the stimulatory effects
of glucose, pyruvate, succinate, or citrate on growth, cell yield, and
viability were compared. At a concentration of 0.2%, none of these
carbon sources supported growth or enhanced the cell yield in batch
culture, and the cell numbers after about 22 h of incubation were
approximately 6 × 108 CFU/ml in all cultures (Fig.
4). However, after prolonged incubation, there were marked differences in the levels of reduction of the numbers
of viable bacteria in the cultures. All carbon sources improved
viability, but glucose had the most notable effect; after 3 days of
incubation the viability was not reduced by more than about 1 log10, whereas the reduction was about 8 log10
in the culture without an additional carbon source. In another study (n = 1), the presence of glucose retained a high level
of cell viability (>4 log10 CFU/ml) for more than 4 weeks
(Fig. 5). Together these results indicate
that in a defined medium, the presence of an oxidizable substrate
markedly enhanced the viability of H. pylori but not
the cell number.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of glucose on growth of H. pylori
ATCC 43504 in a defined medium plus BSA. , no glucose; , 0.2%
glucose; , 1% glucose.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Growth and viability of H. pylori ATCC
43504 in a defined medium plus BSA in the presence of different carbon
sources: 0.2% glucose ( ), 0.2% pyruvate ( ), 0.2% succinate
( ), 0.2% citrate ( ), or no additional carbon source ( ).
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 5.
Viability after prolonged incubation of H. pylori ATCC 43504 in a defined medium plus BSA without glucose
( ) and with 0.2% glucose ( ).
|
|
MIC and MBCs of Brij 78 for H. pylori in different
media.
The MICs and MBCs of Brij 78 for H. pylori
were read in complex and defined media with different supplements. The
results in Table 1 indicate that the MICs
of Brij 78 were 0.16 to 0.32 µg/ml in BB or the defined medium
supplemented with FCS or BSA. However, in the defined medium
supplemented with CD and cholesterol, the susceptibility to Brij 78 was
increased and the MIC was 0.04 µg/ml. MBCs in all media were four- to
eightfold higher than the MICs.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
MIC and MBC of Brij 78 for H. pylori ATCC
43504 in different media and bactericidal activity in buffer pH 5
|
|
Susceptibility of H. pylori precultured in
different media to Brij 78 in phosphate buffer at pH 5.
The
antibacterial activity of Brij 78 against H. pylori
precultured in different media was determined in 100 mM
citrate-phosphate buffer at pH 5. The results presented in Table 1
indicate that the antibacterial activity is bactericidal at a pH
possible in the habitat of H. pylori and that the
killing mechanism is not growth dependent. Furthermore, there was no
difference in susceptibility between bacteria precultured in different
media, and the lowest concentration of Brij 78 reducing the number of
survival bacteria (numbers of CFU per milliliter) by 5 log10 after an exposure time of 5 h was 1.28 to 2.56 µg/ml.
 |
DISCUSSION |
Although H. pylori is a fastidious organism
requiring special culture conditions in vitro (29), good
growth is now achieved in many complex media (27) and in the
defined medium for helicobacters described by Reynolds and Penn
(26). The growth rates and cell yields in the defined medium
in the presence of 0.2% glucose and 0.5% BSA and in a complex medium
with 5% fetal bovine serum are comparable (26). However,
conversion to the nonculturable coccoid form was observed to be slower
in the defined medium than in the complex medium.
Because the availability of a medium in which all the components were
chemically defined would further facilitate biological studies of
H. pylori, we compared different growth additives in BB
and a defined medium. The level of growth supported by FCS or CD
in BB was about the same. However, the inability of CD to support
growth in the defined medium indicates that some factor(s) supporting
the growth of H. pylori is limiting. The
growth-limiting factor could be cholesterol, which was seen to
stimulate growth in the presence of CD. However, growth in
the presence of cholesterol was not fully comparable to that in the
presence of BSA, and the lag phase obtained in the defined medium may
depend on enzyme induction.
The inability of CD to support growth in the defined medium shows that
BB contains growth-stimulating factors that are present in serum and
that CD probably acts by binding toxic metabolites and is not a real
growth factor. One growth-stimulatory effect of cholesterol may be the
reversal of fatty acid inhibition (6).
Ansorg et al. (1) have shown earlier that H. pylori cells grown on cholesterol-free medium adsorb cholesterol
from serum, and the difficulty of detaching cholesterol by washing the
cells may indicate the intensive binding of cholesterol to the cell surface or even the uptake of cholesterol.
The fact that many Helicobacter spp. have been found to have
unique cholesterol glucosides (9, 10, 12) and that most of
the bacteria having cholesterol glucosides require cholesterol or serum
for growth may explain the growth response obtained by the addition of
cholesterol to the defined medium. Despite the results of nuclear
magnetic resonance studies (3) and the availability of the
genome sequence of H. pylori (30), which
indicate that H. pylori can catabolize glucose
(18, 19), we could not obtain growth enhancement in the
presence of glucose in the defined medium as described by Reynolds and
Penn (26). We have no explanation for this discrepancy, but
it may depend on strain variations similar to the variations in the
requirements for amino acids that have been found. However, if growth
is measured only as an increase in optical density, differences in the
optical density may be obtained, depending on the enhanced
viability (optical density at 560 nm) in the presence of glucose, even
though there is no increase in cell number.
The extension of the viability of H. pylori for weeks
after the cessation of growth in the presence of glucose indicates a slower conversion to the nonculturable form. This may depend on an
oxidative metabolism, demonstrated by substrate-enhanced tetrazolium reduction in nonculturable H. pylori (8). It
may also explain the enhanced cell yield and cell viability obtained
from the glucose in BB supplemented with CD, as shown by Marchini et
al. (16). Conversion of H. pylori to the
nonculturable form in vitro is induced by different agents
(22), and higher amounts of toxic metabolites in complex
media probably accelerate this transfer.
The clinical significance of the nonculturable form found in vivo
(4) and whether the failure of antibiotic treatment of H. pylori may partially depend on the fact that the
nongrowing form is present are being debated.
The bactericidal activity exerted by Brij 78 in buffer at a low pH
mimicking the in vivo environment of H. pylori is
rapid, and the killing mechanism is neither growth nor medium
dependent. These properties make it possible to make the nonculturable
form of helicobacters insusceptible to growth-requiring antibiotics (29). MICs and MBCs are not medium dependent, and a possible difference in the constitution of the cell membrane among H. pylori strains (7) does not affect the susceptibilities
of the strains. However, the higher MICs obtained in
serum-supplemented media probably depend more on the binding of Brij 78 to serum than on the biochemical characteristics of the bacteria,
because the addition of serum to buffer also reduced the bactericidal
activity (data not shown).
In conclusion, our results indicate that studies of the growth of
H. pylori in a medium in which all constituents are
chemically defined are possible in the presence of CD and cholesterol,
in which the addition of glucose enhances cell viability. Furthermore, the antibacterial properties of Brij 78 indicate the potential of using
this type of compound in the eradication of both growing and
nonculturable forms of H. pylori.
 |
ACKNOWLEDGMENTS |
We thank Håkan Larsson for valuable discussions, M.-L. Berglund
for skillful technical assistance, and Lena Ruehl for typing the
manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cell Biology and Biochemistry, Astra Hässle AB, S 43183 Mölndal, Sweden. Phone: 46 31 776 1000. Fax: 46 31 776 3761. E-mail: jan-eric.sjostrom{at}hassle.se.astra.com.
 |
REFERENCES |
| 1.
|
Ansorg, R.,
K.-D. Müller,
G. von Recklinghausen, and H. P. Nalik.
1992.
Cholesterol binding of Helicobacter pylori.
Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig.
276:323-329.
|
| 2.
|
Blaser, M. J.
1990.
Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.
J. Infect. Dis.
161:626-633[Medline].
|
| 3.
|
Chalk, P. A.,
A. D. Roberts, and W. M. Blows.
1994.
Metabolism of pyruvate and glucose by intact cells of Helicobacter pylori studied by 13C NMR spectroscopy.
Microbiology
140:2085-2092[Abstract/Free Full Text].
|
| 4.
|
Chan, W. Y.,
P. K. Hui,
J. Chow,
F. Kwoki, and C. S. Ng.
1994.
Coccoid forms of Helicobacter pylori in the human stomach.
Am. J. Clin. Pathol.
102:503-507[Medline].
|
| 5.
|
Deshpande, M.,
E. Calenoff, and L. Daniels.
1995.
Rapid large-scale growth of Helicobacter pylori in flasks and fermentors.
Appl. Environ. Microbiol.
61:2431-2435[Abstract].
|
| 6.
|
Galbraith, H.,
T. B. Miller,
A. M. Paton, and J. K. Thompson.
1995.
Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol.
J. Appl. Bacteriol.
34:803-813.
|
| 7.
|
Geis, G.,
H. Leying,
S. Suerbaum, and W. Opferkuch.
1990.
Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori.
J. Clin. Microbiol.
28:930-932[Abstract/Free Full Text].
|
| 8.
|
Gribbon, L. T., and M. R. Barer.
1995.
Oxidative metabolism in nonculturable Helicobacter pylori and Vibrio vulnificans cells studied by substrate-enhanced tetrazolium reduction and digital image processing.
Appl. Environ. Microbiol.
61:3379-3384[Abstract].
|
| 9.
|
Haque, M.,
Y. Hirai,
K. Yokota, and K. Oguma.
1995.
Lipid profiles of Helicobacter pylori and Helicobacter mustelae grown in serum-supplemented and serum-free media.
Acta Med. Okayama
49:205-211.
|
| 10.
|
Hague, M.,
Y. Hirai,
K. Yokota, and K. Oguma.
1995.
Steryl glycosides: a characteristic feature of Helicobacter spp.?
J. Bacteriol.
177:5334-5337[Abstract/Free Full Text].
|
| 11.
|
Hazell, S. L., and D. Y. Graham.
1990.
Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori.
J. Clin. Microbiol.
28:1060-1061[Abstract/Free Full Text].
|
| 12.
|
Hirai, Y.,
M. Haque,
T. Yoshida,
K. Yokota,
T. Yasuda, and K. Oguma.
1995.
Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis.
J. Bacteriol.
177:5327-5333[Abstract/Free Full Text].
|
| 13.
|
Kane, A. V., and A. G. Plaut.
1996.
Unique susceptibility of Helicobacter pylori to simethicone emulsifiers in alimentary therapeutic agents.
Antimicrob. Agents Chemother.
40:500-502[Abstract].
|
| 14.
|
Khulusi, S.,
H. A. Ahmed,
P. Patel,
M. A. Mendall, and T. C. Northfield.
1995.
The effects of unsaturated fatty acids on Helicobacter pylori in vitro.
J. Med. Microbiol.
42:276-282[Abstract/Free Full Text].
|
| 15.
|
Lee, A.,
J. Fox, and S. Hazell.
1993.
Pathogenicity of Helicobacter pylori: a perspective.
Infect. Immun.
16:1601-1610.
|
| 16.
|
Marchini, A.,
P. Massari,
R. Manetti, and R. Olivieri.
1994.
Optimized conditions for the fermentation of Helicobacter pylori and production of vacuolating cytotoxin.
FEMS Microbiol. Lett.
124:55-60[Medline].
|
| 17.
|
Marshall, B. J.,
H. Royce,
D. I. Annear,
C. S. Goodwin,
J. W. Pearman,
J. R. Warren, and J. A. Armstrong.
1984.
Original isolation of Campylobacter pyloridis from human gastric mucosa.
Microbios Lett.
25:83-88.
|
| 18.
|
Mendz, G. L., and S. L. Hazell.
1991.
Evidence for a pentose phosphate pathway in Helicobacter pylori.
FEMS Microbiol. Lett.
84:331-336.
|
| 19.
|
Mendz, G. L., and S. L. Hazell.
1993.
Glucose phosphorylation in Helicobacter pylori.
Arch. Biochem. Biophys.
300:522-525[Medline].
|
| 20.
|
Nedenskov, P.
1994.
Nutritional requirements for growth of Helicobacter pylori.
Appl. Environment. Microbiol.
60:3450-3453[Abstract/Free Full Text].
|
| 21.
|
Nieman, C.
1954.
Influence of trace amounts of fatty acids on the growth of microorganisms.
Bacteriol. Rev.
18:147-163[Free Full Text].
|
| 22.
|
Nilius, M.,
A. Ströhle,
G. Bode, and P. Malfertheiner.
1993.
Coccoid-like form (CLF) of Helicobacter pylori. Enzyme activity and antigenicity.
Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig.
280:259-272.
|
| 23.
|
Olivieri, R.,
M. Bugnoli,
D. Armellini,
S. Bianciardi,
R. Rappuoli,
P. F. Bayeli,
L. Abate,
E. Esposito,
L. de Gregorio,
J. Aziz,
C. Basagni, and N. Figura.
1993.
Growth of Helicobacter pylori in media containing cyclodextrins.
J. Clin. Microbiol.
31:160-162[Abstract/Free Full Text].
|
| 24.
|
Parsonnet, J.,
G. D. Friedman,
D. P. Vandersteen,
Y. Chang,
J. H. Vogelman,
N. Orentreich, and R. K. Sibley.
1991.
Helicobacter pylori infection and the risk of gastric carcinoma.
N. Engl. J. Med.
325:1127-1131[Abstract].
|
| 25.
|
Petschow, B. W.,
R. P. Batema, and L. L. Ford.
1996.
Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids.
Antimocrob. Agents Chemother.
40:302-306[Abstract].
|
| 26.
|
Reynolds, D. J., and C. W. Penn.
1994.
Characteristics of Helicobacter pylori growth in a defined medium and determination of its amino acid requirements.
Microbiology
140:2649-2656[Abstract/Free Full Text].
|
| 27.
|
Shahamat, M.,
U. E. H. Mai,
C. Paszko-Kolva,
H. Yamamoto, and R. R. Colwell.
1991.
Evaluation of liquid media for growth of Helicobacter pylori.
J. Clin. Microbiol.
29:2835-2837[Abstract/Free Full Text].
|
| 28.
|
Sjöström, J. E.,
J. Fryklund,
T. Kühler, and H. Larsson.
1996.
In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter pylori spp. are dependent on incubation conditions.
Antimicrob. Agents Chemother.
40:621-626[Abstract].
|
| 29.
|
Sjöström, J. E., and H. Larsson.
1996.
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
J. Med. Microbiol.
44:425-433[Abstract/Free Full Text].
|
| 30.
|
Tomb, J.-F.,
O. White,
A. R. Kerlavge,
R. A. Clayton,
G. G. Sutton,
R. D. Fleischman,
K. A. Ketchum,
H. P. Klenk,
S. Gill,
B. A. Dougherty,
K. Nelson,
J. Quackenbush,
L. Zhou,
E. F. Kirkness,
S. Peterson,
B. Loftus,
D. Richardson,
R. Dodson,
H. G. Khakak,
A. Glodek,
K. McKenney,
L. M. Fizegerald,
N. Lee,
M. D. Adams,
E. K. Hickey,
D. E. Berg,
J. D. Gocayne,
T. R. Utterback,
J. D. Peterson,
J. M. Kelley,
M. D. Cotton,
J. M. Weidman,
C. Fujii,
C. Bowman,
L. Watthey,
E. Wallin,
W. S. Haynes,
M. Borodovsky,
P. D. Karp,
H. O. Smith,
C. M. Fraser, and J. C. Venter.
1997.
The complete genome sequence of the gastric pathogen Helicobacter pylori.
Nature
388:539-547[Medline].
|
Journal of Clinical Microbiology, May 1998, p. 1232-1235, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Weinberg, M. V., Maier, R. J.
(2007). Peptide Transport in Helicobacter pylori: Roles of Dpp and Opp Systems and Evidence for Additional Peptide Transporters. J. Bacteriol.
189: 3392-3402
[Abstract]
[Full Text]
-
Vega, A. E., Cortinas, T. I., Mattana, C. M., Silva, H. J., Puig de Centorbi, O.
(2003). Growth of Helicobacter pylori in Medium Supplemented with Cyanobacterial Extract. J. Clin. Microbiol.
41: 5384-5388
[Abstract]
[Full Text]
-
Bumann, D., Aksu, S., Wendland, M., Janek, K., Zimny-Arndt, U., Sabarth, N., Meyer, T. F., Jungblut, P. R.
(2002). Proteome Analysis of Secreted Proteins of the Gastric Pathogen Helicobacter pylori. Infect. Immun.
70: 3396-3403
[Abstract]
[Full Text]
-
Testerman, T. L., McGee, D. J., Mobley, H. L. T.
(2001). Helicobacter pylori Growth and Urease Detection in the Chemically Defined Medium Ham's F-12 Nutrient Mixture. J. Clin. Microbiol.
39: 3842-3850
[Abstract]
[Full Text]